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Many biologically active compounds, including some important anticancer drugs, 
include the indole nucleus. Three new indole derivatives recently obtained (structures 
shown below) were evaluated for their capacity to inhibit the in vitro growth of three 
human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell 
lung cancer), and SF-268 (CNS cancer). Compound 1 showed the better results in all the 
three tumor cell lines (GI50 11-17 µM), compound 2 showed only a moderated growth 
inhibitory effect in all cell lines and compound 3 showed better results for NCI-460 cell 
line (GI50 18 µM) [1]. 
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Fluorescence emission and fluorescence anisotropy studies of these compounds 
incorporated in lipid aggregates of DPPC (dipalmitoyl phosphatidylcholine), DOPE 
(dioleoyl phosphatidylethanolamine) and Egg-PC (egg yolk phosphatidylcholine) 
indicate that compounds 1 and 3 are located near the hydrophobic lipid tails and are able 
to detect the gel to liquid-crystalline phase of DPPC.  
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